Final results and subgroup analyses of the phase 3 CAIRO3 study: Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer (mCRC).
Miriam Koopman
No relevant relationships to disclose
Lieke Simkens
No relevant relationships to disclose
Anne May
No relevant relationships to disclose
Linda Mol
No relevant relationships to disclose
Harm van Tinteren
No relevant relationships to disclose
Cornelis J. A. Punt
Consultant or Advisory Role - Roche
Honoraria - Roche